4
Changes in Ownership
Xilio Therapeutics, Inc. Filed Acc 0001415889-25-016966
Options or other derivatives
- Director acquired 31,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Shannon James Samuel Director | 2025-06-11 | Grant or award · Stock Option (right to buy) | +31,000 | 31,000 | D | ||
Loading xslF345X05/form4-06122025_080613.xml…